Cool Medicine of the Week: “Killer” Bone marrow transplants
This week we’ve got another cool approach to cancer: Bone marrow transplants that attack the tumor, it’s actually somewhat similar to the approach we covered last week. Like last week, this approach uses immune cells to attack the tumors. This time, though, doctors are taking advantage of some of what are usually considered the problems with bone marrow transplants: Graft versus Host disease. In short, GvH is when immune cells in the bone marrow graft begin attacking the natural cells of the person receiving the graft. The less perfect the match between the graft and the host, the more often this will occur. Usually this means that doctors want to find as close to a perfect match as possible.
A Dr. Velardi in Italy has found that if he takes bone marrow from family members who are only a 50% match to the patient, sometimes immune cells called Natural Killer cells will attack the patient’s tumors, and they do it in a predictable way. This is another one that’s not ready for broad usage yet, but shows potential for some really cool alternatives to the treatments we have now.
If you’re interested in the original report, it can be found here.